Health

Results: 5149-5160 of 6111

SyMRI 3D by SyntheticMR Set for Early 2024 Commercial Launch Post Obtaining CE-Marking

LUMA Vision Co-Founders, CEO Fionn Lahart (right) and Chief Technology Officer Christoph Hennersperger (left). (Photo: Business Wire)

LUMA Vision Announces $22 Million in New Financing to Secure FDA Approval and Advance Development of 4D Cardiac Imaging and Navigation Platform

Implantica adds another RefluxStop™ center in Spain

Clinical Outcomes Solutions & BioSpark AI Technologies Inc. Launch Innovative COA-AI Software

Curia Appoints Gerald Auer as Chief Financial Officer

Takeda Receives Positive CHMP Opinion for HYQVIA® as Maintenance Therapy in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Vertex Receives CHMP Positive Opinion for the First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia

PR Newswire associated0

Tianlong Solution Facilitates the Prevention and Control of Livestock Diseases

PR Newswire associated0

Ping An Receives Hong Kong ESG Excellence Awards 2023

Pre-conditional public offer announced for 100% of the shares in Essity's subsidiary Vinda

Strategic review of the Consumer Tissue Private Label Europe business concluded

QPS Netherlands High Resolution Mass Spectrometry Laboratory in Groningen, The Netherlands. (Photo: Business Wire)

QPS Continues UPLC-HRMS Expansion Into Europe to Support Gene Therapy and Protein Drug Development